Crossmark

Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017

Crossref DOI link: https://doi.org/10.1186/s12879-021-05790-9

Published Online: 2021-02-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boonyasiri, Adhiratha

Jauneikaite, Elita

Brinkac, Lauren M.

Greco, Chris

Lerdlamyong, Kanokorn

Tangkoskul, Teerawit

Nguyen, Kevin

Thamlikitkul, Visanu

Fouts, Derrick E. http://orcid.org/0000-0003-4323-7668
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (U19AI110819)

Health Systems Research Institute, Thailand
License Information

Text and Data Mining valid from 2021-02-04

Version of Record valid from 2021-02-04
More Information

Article History

Received: 21 July 2020

Accepted: 11 January 2021

First Online: 4 February 2021

Ethics approval and consent to participate

: This study protocol was approved by the Siriraj Institutional Review Board (Si571/2015) with written informed consent obtained from all the participating patients.

: Not applicable.

: None declared.

Document is current

Any future updates will be listed below